Surgery Partners, Inc.(SGRY)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Surgery Partners, Inc. (SGRY) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SGRY at 53.1/100 on a 32-signal composite quality model, placing it at rank #1,411 of 2,961 stocks — the top half of the AI-ranked universe. SGRY scores in the top quartile across earnings quality (85.8). Areas of concern include institutional flow (28.3) and balance sheet strength (30.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Surgery Partners, Inc. reports quarterly revenue of $848.9M, net income of $-15.0M, an operating margin of 12.0%. Top institutional holders of SGRY by reported 13-F value include BAIN CAPITAL INVESTORS, Jupiter Topco, Pentwater Capital Management, based on the most recent SEC filings. SGRY trades on the Nasdaq exchange and files with the SEC under CIK 1638833. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SGRY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Surgery Partners, Inc. directly from SEC EDGAR.